Pharmacogenomic characterization of US FDA-approved cytotoxic drugs

Keyphrases

• FDA-approved Drugs 100%
• Drug Class 100%
• Pharmacogenomics 100%
• US FDA 100%
• Cytotoxic Drugs 100%
• Relative Contribution 50%
• Genetic Makeup 50%
• Heritability 50%
• Quantitative Traits 50%
• Shared Genetics 50%
• Drug Response 50%
• Genetic Mechanism 50%
• Cytotoxic Effect 50%
• Cancer Chemotherapy 50%
• Quantitative Trait Loci 50%
• Class-specific 50%
• Lymphoblastoid Cell Lines 50%
• Extended Family 50%
• Cytotoxic Response 50%
• Specific Signature 50%
• Response Components 50%
• Genetic Response 50%
• Variable Roles 50%
• Epirubicin 50%

Biochemistry, Genetics and Molecular Biology

• Genetics 100%
• Pharmacogenomics 100%
• Cytotoxicity 25%
• Quantitative Trait 25%
• Genetic Mechanism 25%
• Epirubicin 25%
• Quantitative Trait Locus 25%
• Individualization 25%
• Drug Response 25%